Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ANCA-associated small-vessel vasculitis.

Ishak A Mansi1, Adriana Opran, Fred Rosner

  • 1Mount Sinai Services at Queens Hospital Center, Jamaica, New York 11432, USA.

American Family Physician
|May 7, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Examining the association of dipeptidyl peptidase-4 inhibitors with autoimmune blistering disorders in the U.S. Military veterans.

Cutaneous and ocular toxicology·2026
Same author

Association of acamprosate versus gabapentinoids with liver disease progression and alcohol-related admissions in patients with alcohol use disorder.

European journal of hospital pharmacy : science and practice·2026
Same author

GLP-1 Receptor Agonists Initiation and Risk of Acute Pancreatitis and Pancreatic Cancer: A Real-World Comparative Study.

American journal of medicine open·2025
Same author

Authors' Response to Weng et al.'s Comment on "Association of GLP1-Receptor Agonists with Risk of Hepatocellular Carcinoma: A Retrospective Cohort Study".

Drug safety·2025
Same author

Colorectal Cancer Characteristics and Mortality From Propensity Score-Matched Cohorts of Urban and Rural Veterans.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2025
Same author

Association of GLP1-receptor agonist use with liver disease progression, major cardiovascular events, and mortality in people with hepatic steatosis and diabetes.

Diabetes, obesity & metabolism·2025
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles

Antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis is a common small-vessel disease. Early diagnosis and treatment with corticosteroids and immunosuppressants are crucial for preventing organ damage.

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis is the most common primary systemic small-vessel vasculitis in adults.
  • Diagnosis and management can be challenging due to rarity, evolving terminology, and diverse clinical presentations.

Purpose of the Study:

  • To provide an overview of ANCA-associated vasculitis.
  • To highlight diagnostic criteria and management strategies for family physicians.

Main Methods:

  • Review of current literature and clinical guidelines.
  • Discussion of diagnostic features including organ involvement, ANCA type, cryoglobulins, and granulomatous inflammation.

Main Results:

  • ANCA-associated small-vessel vasculitis encompasses microscopic polyangiitis, granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis, and drug-induced vasculitis.

Related Experiment Videos

  • Diagnostic clarity is improving with advanced technologies and defined criteria.

    • Conclusions:

    • Family physicians must be familiar with ANCA-associated vasculitis for prompt diagnosis and intervention.
    • Treatment typically involves corticosteroids and immunosuppressive agents to prevent end-organ damage.